Top Markets
Coin of the day
Kadimastem Ltd Kadimastem Ltd

Kadimastem Ltd

KDST
Rang in aandelen #41016
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Aandeelprijs
$12.16
Laatst gesynchroniseerd: 2025-10-30
Marktkapitalisatie
$50.98K
Verandering (1 dag)
-0.10%
Verandering (1 jaar)
56.95%
Land
IL
Handel Kadimastem Ltd (KDST)

Categorie

Dividendrendementgeschiedenis voor Kadimastem Ltd (KDST)
Het dividendrendement (TTM) van Kadimastem Ltd (aandelsymbool: KDST) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Kadimastem Ltd (KDST) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten